XIV Scientific and educational conference of cardiology and internal medicine of the Caucasus

Percutaneous coronary intervention plus medical therapy versus medical therapy alone in chronic coronary syndrome: a propensity score-matched analysis from the Swedish Coronary Angiography an Percutaneous coronary intervention (PCI) is frequently used for patients with chronic coronary syndrome (CCS). However, the role of PCI beyond symptom relief in CCS remains controversial. The objective of this study was to determine whether PCI is associated with better outcomes, compared with medical therapy (MT) alone.

Maternal Serum Folate Levels During Pregnancy Linked to Congenital Heart Disease Risk Maternal serum folate levels during early to midpregnancy show a U-shaped association with congenital heart disease (CHD) risk in offspring. Both low and high folate levels are linked to an increased risk, with vitamin B12 deficiency and elevated homocysteine levels further exacerbating this risk.

AI Excludes Heart Attack Better Than Specialist Criteria A machine-learning–based artificial intelligence (AI) program developed by German researchers rapidly and easily rules out a heart attack in patients presenting with chest pain in the emergency department. In a retrospective study, the program named ARTEMIS performed significantly better than traditional diagnostic criteria.

Time-Restricted Eating May Help Adults With Metabolic Syndrome Improve Several Health Markers According to a randomized controlled trial, adults with metabolic syndrome and elevated blood sugar levels who eat for a limited time may experience minor improvements in several indicators, including A1c levels, weight, and body fat.

Impact of multiple obesity metrics on hypertensive disorders of pregnancy: a meta-analysis and Mendelian randomisation study This study demonstrates that various obesity measures are causally linked to increased HDP risk and highlights the mediating role of triglycerides. These findings could inform clinical practices and public health strategies aimed at reducing HDP through targeted obesity and triglyceride management.

CARDIOPROGRESS
Foundation for the advancement of cardiology